HHS Proposes Formulary Changes For Marketplace Health Plans: P&T Committees Would Take On a More Visible Role.

نویسنده

  • Stephen Barlas
چکیده

The federal government is proposing changes to the pharmacy benefit of marketplace plans in 2016 that (among other things) would increase the power of P&T committees, revise minimum "drug count" standards, and tighten conflict-of-interest rules.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Formulary Policies a Battleground In HHS Proposal on Nondiscrimination: Are Tiering and Cost Sharing Civil Rights Issues?

The Department of Health and Human Services' proposed rule on Section 1557 of the Patient Protection and Affordable Care Act bans discrimination in health care. How the rule would affect formularies and P&T committees has prompted varying concerns.

متن کامل

Talk of a "Default" Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already Started.

A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.

متن کامل

Imperatives for Oversight Of Professional Personnel.

Although the health care marketplace is changing rapidly, some things have not changed, including the need for P&T committees and organizations' management to beware of ethical and legal issues such as discrimination, quotas, and understaffing.

متن کامل

Health Plans and Drug Companies Dip Their Toes Into Value-Based Pricing: The Pressure Is on P&T Committees to Monitor Utilization.

The agreement between Harvard Pilgrim and Amgen on a "pay for performance" deal involving evolocumab could encourage other manufacturers, health plans, and policy-makers to press for value-based pricing as drug costs continue to escalate.

متن کامل

Insurance companies struggle to balance medical and pharmacy networks: cost and access are often at odds; enrollees are caught in the middle.

Confusion over which physicians, facilities, and pharmacies are in insurance companies' networks has become an issue among enrollees in marketplace plans under health care reform, Medicare Advantage plans, and even accountable care organizations.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • P & T : a peer-reviewed journal for formulary management

دوره 40 2  شماره 

صفحات  -

تاریخ انتشار 2015